ID   IL1R2_RAT               Reviewed;         416 AA.
AC   P43303; Q5BJ99;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 1.
DT   02-OCT-2024, entry version 151.
DE   RecName: Full=Interleukin-1 receptor type 2;
DE            Short=IL-1R-2;
DE            Short=IL-1RT-2;
DE            Short=IL-1RT2;
DE   AltName: Full=CD121 antigen-like family member B;
DE   AltName: Full=IL-1 type II receptor;
DE   AltName: Full=Interleukin-1 receptor beta;
DE            Short=IL-1R-beta;
DE   AltName: Full=Interleukin-1 receptor type II;
DE   AltName: CD_antigen=CD121b;
DE   Contains:
DE     RecName: Full=Interleukin-1 receptor type 2, membrane form;
DE              Short=mIL-1R2;
DE              Short=mIL-1RII;
DE   Contains:
DE     RecName: Full=Interleukin-1 receptor type 2, soluble form;
DE              Short=sIL-1R2;
DE              Short=sIL-1RII;
DE   Flags: Precursor;
GN   Name=Il1r2; Synonyms=Il-1r2, Il1rb;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=7524717;
RA   Bristulf J., Gatti S., Malinowsky D., Bjork L., Sundgren A.K., Bartfai T.;
RT   "Interleukin-1 stimulates the expression of type I and type II interleukin-
RT   1 receptors in the rat insulinoma cell line Rinm5F; sequencing a rat type
RT   II interleukin-1 receptor cDNA.";
RL   Eur. Cytokine Netw. 5:319-330(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Non-signaling receptor for IL1A, IL1B and IL1RN. Reduces IL1B
CC       activities. Serves as a decoy receptor by competitive binding to IL1B
CC       and preventing its binding to IL1R1. Also modulates cellular response
CC       through non-signaling association with IL1RAP after binding to IL1B.
CC       IL1R2 (membrane and secreted forms) preferentially binds IL1B and
CC       poorly IL1A and IL1RN. The secreted IL1R2 recruits secreted IL1RAP with
CC       high affinity; this complex formation may be the dominant mechanism for
CC       neutralization of IL1B by secreted/soluble receptors (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Associates with IL1RAP to form a non-signaling interleukin-1
CC       receptor complex. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.
CC       Cell membrane {ECO:0000250}. Secreted {ECO:0000250}.
CC   -!- PTM: A soluble form (sIL1R2) can also be produced by proteolytic
CC       cleavage at the cell surface (shedding) involving a metalloproteinase.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the interleukin-1 receptor family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z22812; CAA80465.1; -; mRNA.
DR   EMBL; BC091564; AAH91564.1; -; mRNA.
DR   PIR; S33473; S33473.
DR   RefSeq; NP_446405.1; NM_053953.1.
DR   RefSeq; XP_008765206.1; XM_008766984.2.
DR   RefSeq; XP_017451737.1; XM_017596248.1.
DR   AlphaFoldDB; P43303; -.
DR   SMR; P43303; -.
DR   STRING; 10116.ENSRNOP00000019415; -.
DR   GlyCosmos; P43303; 4 sites, No reported glycans.
DR   GlyGen; P43303; 4 sites.
DR   PhosphoSitePlus; P43303; -.
DR   PaxDb; 10116-ENSRNOP00000019415; -.
DR   GeneID; 117022; -.
DR   KEGG; rno:117022; -.
DR   UCSC; RGD:621147; rat.
DR   AGR; RGD:621147; -.
DR   CTD; 7850; -.
DR   RGD; 621147; Il1r2.
DR   eggNOG; ENOG502QVTS; Eukaryota.
DR   HOGENOM; CLU_051287_0_0_1; -.
DR   InParanoid; P43303; -.
DR   OrthoDB; 4293257at2759; -.
DR   PhylomeDB; P43303; -.
DR   TreeFam; TF325519; -.
DR   Reactome; R-RNO-9020702; Interleukin-1 signaling.
DR   PRO; PR:P43303; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0019966; F:interleukin-1 binding; ISO:RGD.
DR   GO; GO:0004908; F:interleukin-1 receptor activity; ISO:RGD.
DR   GO; GO:0004910; F:interleukin-1, type II, blocking receptor activity; IEA:InterPro.
DR   GO; GO:1900016; P:negative regulation of cytokine production involved in inflammatory response; ISO:RGD.
DR   GO; GO:0032690; P:negative regulation of interleukin-1 alpha production; ISO:RGD.
DR   GO; GO:2000660; P:negative regulation of interleukin-1-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0010955; P:negative regulation of protein processing; ISO:RGD.
DR   GO; GO:0016485; P:protein processing; ISO:RGD.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 3.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR015621; IL-1_rcpt_fam.
DR   InterPro; IPR004074; IL-1_rcpt_I/II-typ.
DR   InterPro; IPR004077; IL-1_rcpt_II-typ.
DR   InterPro; IPR013151; Immunoglobulin_dom.
DR   PANTHER; PTHR11890; INTERLEUKIN-1 RECEPTOR FAMILY MEMBER; 1.
DR   PANTHER; PTHR11890:SF3; INTERLEUKIN-1 RECEPTOR TYPE 2; 1.
DR   Pfam; PF00047; ig; 1.
DR   PRINTS; PR01539; INTRLEUKN1R2.
DR   PRINTS; PR01536; INTRLKN1R12F.
DR   SMART; SM00409; IG; 3.
DR   SMART; SM00408; IGc2; 2.
DR   SUPFAM; SSF48726; Immunoglobulin; 3.
DR   PROSITE; PS50835; IG_LIKE; 3.
PE   2: Evidence at transcript level;
KW   Cell membrane; Disulfide bond; Glycoprotein; Immunoglobulin domain;
KW   Membrane; Receptor; Reference proteome; Repeat; Secreted; Signal;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL          1..13
FT                   /evidence="ECO:0000255"
FT   CHAIN           14..416
FT                   /note="Interleukin-1 receptor type 2, membrane form"
FT                   /id="PRO_0000015441"
FT   CHAIN           14..?
FT                   /note="Interleukin-1 receptor type 2, soluble form"
FT                   /id="PRO_0000415350"
FT   TOPO_DOM        14..355
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        356..381
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        382..416
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          29..136
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          146..233
FT                   /note="Ig-like C2-type 2"
FT   DOMAIN          249..357
FT                   /note="Ig-like C2-type 3"
FT   REGION          396..416
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CARBOHYD        124
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        208
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        231
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        289
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        42..128
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        64..120
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        164..219
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        270..338
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
SQ   SEQUENCE   416 AA;  46353 MW;  50EFBA48881C5D4E CRC64;
     MFILLVLVTG VSAFTTPAVV HTGRVSESPV TSEKHPVLGD DCWFRGRDFK SELRLEGEPV
     VLRCPLVPHS DTSSSSRSLL TWSKSDSSQL IPGDEPRMWV KDDTLWVLPA VQQDSGTYIC
     TFRNASHCEQ MSLELKVFKN TEASFPLVSY LQISALSSTG LLVCPDLKEF ISSRTDGKIQ
     WYKGSILLDK GNKKFLSAGD PTRLLISNTS MGDAGYYRCV MTFTYEGKEY NITRNIELRV
     KGITTEPIPV IISPLETIPA SLGSRLIVPC KVFLGTGTSS NTIVWWMANS TFISVAYPRG
     RVTEGLHHQY SENDENYVEV SLIFDPVTKE DLNTDFKCVA TNPRSFQSLH TTVKEVSSTF
     SWGIALAPLS LIILVVGAIW IRRRCKRQAG KTYGLTKLPT DNQDFPSSPN QIKEMK
//
